| Dr Mark Alan Mashia Jr, DC | |
|
500 Chase Pkwy, Waterbury, CT 06708-3346 | |
| (203) 755-6677 | |
| (203) 755-7166 |
| Full Name | Dr Mark Alan Mashia Jr |
|---|---|
| Gender | Male |
| Speciality | Chiropractic |
| Experience | 27 Years |
| Location | 500 Chase Pkwy, Waterbury, Connecticut |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1659352870 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 111N00000X | Chiropractor | 1279 (Connecticut) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Neurosurgery Orthopaedics And Spine Specialists Pc | 8820087463 | 15 |
News Archive
Isotechnika Pharma Inc. announces that the results of the CONFIRM1 clinical trial conducted by its medical device partner, Atrium Medical Corporation, were presented by Glenn Van Langenhove, MD, PhD (Middelheim Hospital in Antwerp, Belgium), the principal investigator, at the Transcatheter Cardiovascular Therapeutics (TCT) 2010 Scientific Symposium in Washington, DC last week.
Researchers with Deakin's Centre for Physical Activity and Nutrition Research surveyed more than 1200 families to find out if parents had concerns about their children's weight and if they took any preventative action to avoid obesity in their children.
A team of scientists from the United States has recently engineered a pre-existing anti-severe acute respiratory syndrome coronavirus (SARS-CoV) neutralizing antibody to increase its binding affinity for the spike receptor-binding domain (RBD) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The engineered antibody demonstrates high potency in neutralizing SARS-CoV-2 and preventing infection in animals.
As the prevalence of childhood obesity approaches epidemic levels, physicians on the "front line" need to become more involved in obesity prevention and weight management to reverse this dangerous trend among their young patients. But several obstacles discourage pediatricians and other primary care physicians from taking a more active role in managing childhood obesity.
Surgeons at the Methodist DeBakey Heart Center in Houston were among the first in the U.S. to implant a new, less-invasive stent graft designed to reduce the risk of blood clots in patients treated for peripheral arterial disease (PAD), which affects as many as 12 million Americans over the age of 50.
› Verified 7 days ago
| Provider Name | Neurosurgery Orthopaedics & Spine Specialists Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1831359215 PECOS PAC ID: 8820087463 Enrollment ID: O20040510000696 |
News Archive
Isotechnika Pharma Inc. announces that the results of the CONFIRM1 clinical trial conducted by its medical device partner, Atrium Medical Corporation, were presented by Glenn Van Langenhove, MD, PhD (Middelheim Hospital in Antwerp, Belgium), the principal investigator, at the Transcatheter Cardiovascular Therapeutics (TCT) 2010 Scientific Symposium in Washington, DC last week.
Researchers with Deakin's Centre for Physical Activity and Nutrition Research surveyed more than 1200 families to find out if parents had concerns about their children's weight and if they took any preventative action to avoid obesity in their children.
A team of scientists from the United States has recently engineered a pre-existing anti-severe acute respiratory syndrome coronavirus (SARS-CoV) neutralizing antibody to increase its binding affinity for the spike receptor-binding domain (RBD) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The engineered antibody demonstrates high potency in neutralizing SARS-CoV-2 and preventing infection in animals.
As the prevalence of childhood obesity approaches epidemic levels, physicians on the "front line" need to become more involved in obesity prevention and weight management to reverse this dangerous trend among their young patients. But several obstacles discourage pediatricians and other primary care physicians from taking a more active role in managing childhood obesity.
Surgeons at the Methodist DeBakey Heart Center in Houston were among the first in the U.S. to implant a new, less-invasive stent graft designed to reduce the risk of blood clots in patients treated for peripheral arterial disease (PAD), which affects as many as 12 million Americans over the age of 50.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mark Alan Mashia Jr, DC 500 Chase Pkwy, Waterbury, CT 06708-3346 Ph: (203) 755-6677 | Dr Mark Alan Mashia Jr, DC 500 Chase Pkwy, Waterbury, CT 06708-3346 Ph: (203) 755-6677 |
News Archive
Isotechnika Pharma Inc. announces that the results of the CONFIRM1 clinical trial conducted by its medical device partner, Atrium Medical Corporation, were presented by Glenn Van Langenhove, MD, PhD (Middelheim Hospital in Antwerp, Belgium), the principal investigator, at the Transcatheter Cardiovascular Therapeutics (TCT) 2010 Scientific Symposium in Washington, DC last week.
Researchers with Deakin's Centre for Physical Activity and Nutrition Research surveyed more than 1200 families to find out if parents had concerns about their children's weight and if they took any preventative action to avoid obesity in their children.
A team of scientists from the United States has recently engineered a pre-existing anti-severe acute respiratory syndrome coronavirus (SARS-CoV) neutralizing antibody to increase its binding affinity for the spike receptor-binding domain (RBD) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The engineered antibody demonstrates high potency in neutralizing SARS-CoV-2 and preventing infection in animals.
As the prevalence of childhood obesity approaches epidemic levels, physicians on the "front line" need to become more involved in obesity prevention and weight management to reverse this dangerous trend among their young patients. But several obstacles discourage pediatricians and other primary care physicians from taking a more active role in managing childhood obesity.
Surgeons at the Methodist DeBakey Heart Center in Houston were among the first in the U.S. to implant a new, less-invasive stent graft designed to reduce the risk of blood clots in patients treated for peripheral arterial disease (PAD), which affects as many as 12 million Americans over the age of 50.
› Verified 7 days ago
Dr. Joseph Pacheco Sr., D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1869 E Main St, Waterbury, CT 06705 Phone: 203-597-8303 Fax: 203-597-8315 | |
Tribury Orthopaedics Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 500 Chase Pkwy, Waterbury, CT 06708 Phone: 203-755-4281 Fax: 203-755-7166 | |
Waterbury Family Chiropractic, Llc Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 431 Meriden Rd, Waterbury, CT 06705 Phone: 203-753-8800 | |
Steven Rosa, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 715 Lakewood Rd, Waterbury, CT 06704 Phone: 203-573-0011 Fax: 203-597-1809 | |
Ct Junction Chiropractic Chiropractor Medicare: Medicare Enrolled Practice Location: 93 Meriden Rd Unit 2, Waterbury, CT 06705 Phone: 203-490-9173 | |
Active Life Chiropractic Chiropractor Medicare: Medicare Enrolled Practice Location: 255 Robbins St, Waterbury, CT 06708 Phone: 203-573-8577 | |
Brass City Chiropractic Center, Llc Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 11 Scovill St, Suite 104, Waterbury, CT 06706 Phone: 203-757-7246 Fax: 203-757-7247 |